Lingyin Chiu

I am a senior clinical research study coordinator for the clinical trials. In each project, I am main person of project management (including the site monitor preparation and inspection, site IRB management), cooperating communication, laboratory sample processing/preparation/shipment, electronic database management. Since 2014, I was mainly joined the Phase II and III trials and cooperated were GSK, Rigel, AbbVie, Novartis and Roche.

I worked both in London and Taiwan. I am the person work for all the experiment performance and publication writing. The data been published in the international journal as below: 1.Identification of ceruloplasmin as a gene that affects susceptibility to glomerulonephritis through macrophage function. Genetics, genetics-116.. 2. Unique regulatory properties of mesangial cells are genetically determined in the rat. PloS one, 9(10).

The Signaling Mechanism Underlying CCN1-induced Apoptosis